Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION

(CVS)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

CVS Health : S&P Downgrades CVS After News of Bond Sale

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/06/2018 | 11:31am EDT

By Imani Moise

Standard & Poor's Global Ratings downgraded CVS Health Co debt rating to one notch above non-investment grade after the pharmacy operator announced plans to sell $44 billion in bonds to fund its $69 billion acquisition of Aetna Inc..

The offering marks the largest bond sale in more than two years.

The ratings firm lowered CVS's position to BBB from BBB+, saying that the company's financial risk profile will weaken considerable from the substantial increase in debt. The firm said CVS's outlook is stable as it expects the company to pay down some debt.

According to the S&P website, debt rated BBB has sufficient protection parameters but "adverse economic conditions or changing circumstances are more likely to weaken the obligor's capacity to meet its financial commitments on the obligation."

Shares fell 0.8% to $67.76 during morning trading and have fallen 16% over the past year.

Write to Imani Moise at imani.moise@wsj.com

Stocks mentioned in the article : CVS Health, Aetna
Stocks mentioned in the article
ChangeLast1st jan.
CVS HEALTH CORPORATION -2.37% 56.04 Delayed Quote.-12.39%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORPORATION
10:43aCVS HEALTH : to sell topical CBD products made from cannabis extract
AQ
03/21CVS HEALTH : Aetna Offers Assistance to Members Affected by Flooding in the Midw..
PR
03/19CVS HEALTH : Fights Rise In E-Cigarette Use Among Young Adults With More Than $1..
PU
03/16Rosen Law Firm Reminds CVS Health Corporation Investors with Over $200K in Lo..
BU
03/15CVS SHAREHOLDER ALERT BY FORMER LOUI : Kahn Swick & Foti, LLC Reminds Investors ..
BU
03/14WALGREENS BOOTS ALLIANCE : Names Heather Dixon Chief Accounting Officer
DJ
03/13GLANCY PRONGAY & MURRAY LLP : Reminds Investors of the Deadline in the Class Act..
BU
03/13CVS HEALTH : US stocks open higher, led by technology and health care
AQ
03/12IMPORTANT INVESTOR REMINDER : The Schall Law Firm Announces the Filing of a Clas..
BU
03/11DEADLINE REMINDER : The Law Offices of Howard G. Smith Reminds Investors of Loom..
BU
More news
Financials ($)
Sales 2019 252 B
EBIT 2019 13 830 M
Net income 2019 6 528 M
Debt 2019 62 744 M
Yield 2019 3,44%
P/E ratio 2019 11,52
P/E ratio 2020 10,12
EV / Sales 2019 0,55x
EV / Sales 2020 0,50x
Capitalization 74 453 M
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 76,8 $
Spread / Average Target 34%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Eva C. Boratto Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors